BHATIA, N. .; KANTOR, J. .; GREEN, L. .; WEISS, J. .; WILLSON, C.; CUTLER, S.; RIEGER, J.; GLOVER, D. K.; RUMNEY, P.; GOLDENBERG, G. Results from Part 1 Safety Run-in Period of a 2-part, Phase 2, Multicenter, Open-label, Proof-of-Concept Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VP-315 in Subjects with Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s260, 2023. DOI: 10.25251/skin.7.supp.260. Disponível em: https://jofskin.org/index.php/skin/article/view/2333. Acesso em: 3 jul. 2024.